@article{ambrosi:inserm-03090462,
  TITLE = {{Authors' Reply to the Letter by Shoar et al. on ``Glycosylated Hemoglobin as a Surrogate for the Prevention of Cardiovascular Events in Cardiovascular Outcome Trials Comparing New Antidiabetic Drugs to Placebo''}},
  AUTHOR = {Ambrosi, Pierre and Daumas, Aur{\'e}lie and Villani, Patrick and Giorgi, Roch},
  URL = {https://inserm.hal.science/inserm-03090462},
  JOURNAL = {{Cardiology}},
  PUBLISHER = {{Karger}},
  VOLUME = {145},
  NUMBER = {6},
  PAGES = {387-387},
  YEAR = {2020},
  MONTH = Jun,
  DOI = {10.1159/000507361},
  PDF = {https://inserm.hal.science/inserm-03090462v1/file/Cardiology507361May2020.pdf},
  HAL_ID = {inserm-03090462},
  HAL_VERSION = {v1},
}